Genetech Pharmaceuticals, a fast-growing pharmaceutical exporter founded in 2019, will attend WHX Dubai 2026 as part of its strategy to expand its global network and connect with both new international supply partners and international customers across key global markets.
Established to meet increasing global demand for high-quality pharmaceutical products, Genetech Pharmaceuticals operates on a business model centred on efficiency, regulatory compliance and competitive pricing. Although relatively young, the company is led by a team with extensive experience across pharmaceutical sourcing, international compliance, logistics and global trade.
As a specialist pharmaceutical wholesaler, Genetech Pharmaceuticals focuses on the ethical and fully compliant supply of medicines to international markets. This includes supporting access to pharmaceutical products that may not be commercially available in certain destination countries. Its operations are underpinned by a detailed understanding of international regulatory frameworks, documentation requirements and quality standards, ensuring consistency and compliance across global shipments.
The company’s experienced team enables it to navigate the complexities of the global pharmaceutical supply chain, optimising sourcing routes and logistics pathways to deliver essential medicines efficiently. As international markets continue to face supply chain disruption and evolving regulatory pressures, this capability has become increasingly critical.
Speed and reliability remain central to Genetech Pharmaceuticals’ operating model. Streamlined internal processes and established logistics partnerships allow the company to reduce lead times while maintaining uncompromised standards of safety, quality and regulatory compliance. This operational focus has contributed to the company’s growing reputation among international buyers, distributors and partners.
Alongside operational efficiency, Genetech Pharmaceuticals maintains a strong emphasis on competitive pricing. Through optimised sourcing strategies and long-standing global supplier relationships, the company delivers cost-effective pharmaceutical solutions without compromising product integrity or service reliability.
Kushal Patel, Head of International Procurement & NHS Sales for Genetech Pharmaceuticals, said:
“WHX Dubai provides an important platform for building new international relationships and strengthening global supply chains. We are keen to connect not only with manufacturers and suppliers who share our commitment to quality, compliance and reliability, but also with international customers seeking a responsive export partner capable of delivering safe, compliant and competitively priced medicines to global markets.”
Beyond supply, Genetech Pharmaceuticals positions itself as a long-term partner, working closely with regulatory authorities, healthcare professionals and industry stakeholders to ensure alignment with global standards and support improved access to medicines. Transparency, responsiveness and consistency remain core principles guiding its partnerships.
As the company continues to grow, its participation at WHX Dubai 2026 reflects an ongoing commitment to expanding global reach, strengthening international collaborations and supporting resilient pharmaceutical supply chains worldwide.
For more information: https://www.genetechpharmaceuticals.com/
